MX2007015718A - Inhibidor de tubulina y proceso para su preparacion. - Google Patents

Inhibidor de tubulina y proceso para su preparacion.

Info

Publication number
MX2007015718A
MX2007015718A MX2007015718A MX2007015718A MX2007015718A MX 2007015718 A MX2007015718 A MX 2007015718A MX 2007015718 A MX2007015718 A MX 2007015718A MX 2007015718 A MX2007015718 A MX 2007015718A MX 2007015718 A MX2007015718 A MX 2007015718A
Authority
MX
Mexico
Prior art keywords
pyrazin
process according
amine
phenyl
chloro
Prior art date
Application number
MX2007015718A
Other languages
English (en)
Spanish (es)
Inventor
Yanzhong Wu
David Michael Blum
Jean Schmid
Jay Thomas Afragola
Timothy John Doyle
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37074929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007015718(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MX2007015718A publication Critical patent/MX2007015718A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2007015718A 2005-06-13 2006-06-08 Inhibidor de tubulina y proceso para su preparacion. MX2007015718A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69001605P 2005-06-13 2005-06-13
US80278106P 2006-05-24 2006-05-24
PCT/US2006/022574 WO2006138180A1 (fr) 2005-06-13 2006-06-08 Inhibiteur de tubuline et sa methode de preparation

Publications (1)

Publication Number Publication Date
MX2007015718A true MX2007015718A (es) 2008-02-21

Family

ID=37074929

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007015718A MX2007015718A (es) 2005-06-13 2006-06-08 Inhibidor de tubulina y proceso para su preparacion.

Country Status (12)

Country Link
EP (1) EP1891052A1 (fr)
JP (1) JP2008543838A (fr)
AR (1) AR054392A1 (fr)
AU (1) AU2006259663A1 (fr)
BR (1) BRPI0612145A2 (fr)
CA (1) CA2610416A1 (fr)
GT (1) GT200600257A (fr)
MX (1) MX2007015718A (fr)
PE (1) PE20070114A1 (fr)
SV (1) SV2007002573A (fr)
TW (1) TW200716613A (fr)
WO (1) WO2006138180A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2581207T3 (es) 2009-11-12 2016-09-02 Tube Pharmaceuticals Gmbh Inhibidores de la tubulina
EP2903436B1 (fr) * 2012-09-19 2019-07-17 The Trustees Of The University Of Pennsylvania Composés hétérocycliques et leur utilisation pour le traitement de tauopathies neurodégénératives
WO2017181974A1 (fr) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 Composé hétérocyclique à cinq chaînons, procédé de préparation correspondant, composition pharmaceutique et utilisation
WO2019169111A1 (fr) 2018-03-02 2019-09-06 The Trustees Of The University Of Pennsylvania Composés de [1,2,4]triazolo[1,5-a]pyrimidine et utilisation de ces derniers dans la stabilisation de microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003207A (es) * 2003-09-24 2006-06-23 Wyeth Corp 5-arilpirimidinas como agentes anti-cancer.
CN100519559C (zh) * 2003-09-24 2009-07-29 惠氏控股公司 作为抗癌剂的6-[(经取代的)苯基]三唑并嘧啶

Also Published As

Publication number Publication date
AU2006259663A1 (en) 2006-12-28
SV2007002573A (es) 2007-01-03
PE20070114A1 (es) 2007-02-03
BRPI0612145A2 (pt) 2010-10-19
TW200716613A (en) 2007-05-01
EP1891052A1 (fr) 2008-02-27
JP2008543838A (ja) 2008-12-04
GT200600257A (es) 2007-02-14
AR054392A1 (es) 2007-06-20
CA2610416A1 (fr) 2006-12-28
WO2006138180A1 (fr) 2006-12-28

Similar Documents

Publication Publication Date Title
US10946016B2 (en) Solid forms of an epidermal growth factor receptor kinase inhibitor
US10618884B2 (en) Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds
US5856481A (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US8124763B2 (en) Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine
JP2018021072A (ja) 治療活性化合物およびそれらの使用方法
USRE43098E1 (en) Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
JP4733021B2 (ja) 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤
US10287254B2 (en) Salts of a dihydroquinazoline derivative
EP0303697A1 (fr) Derives de la substance physiologiquement active k-252
CN105153122A (zh) [(吲哚-3-基)嘧啶-2-基]氨基苯基丙-2-烯酰胺衍生物及盐、制备方法、应用
AU2016292450A1 (en) Aniline pyrimidine derivatives and uses thereof
US20230250087A1 (en) Solid forms of apol1 inhibitor and methods of using same
JP2008501775A (ja) オキシトシン拮抗剤としての置換トリアゾール誘導体
KR20180127979A (ko) 화합물 (s)-4-((s)-3-플루오로-3-(2-(5,6,7,8-테트라히드로-1,8-나프티리딘-2-일)에틸)피롤리딘-1-일)-3-(3-(2-메톡시에톡시)페닐) 부탄산의 시트레이트 염
JP2023036991A (ja) Ｅｈｍｔ２阻害剤としてのアミン置換複素環化合物、その塩、及びそれらの合成方法
US9458165B2 (en) DOT1L inhibitors
MX2007015718A (es) Inhibidor de tubulina y proceso para su preparacion.
US7501423B2 (en) Tubulin inhibitor and process for its preparation
US20160074399A1 (en) Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
CN113557236B (zh) 一种双功能免疫调节剂及其在药学上可接受的盐、药物组合物
US11964987B2 (en) Isoidide derivatives and methods of making and using same
US5179204A (en) N-substituted-4-pyrimidinamines and pyrimidinediamines

Legal Events

Date Code Title Description
FA Abandonment or withdrawal